These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 20826836

  • 1. Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy.
    Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, Scalisi A, Macis R, Chini F, Buonaguro FM, Giorgi Rossi P, HPV Prevalence Italian Working Group.
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2389-400. PubMed ID: 20826836
    [Abstract] [Full Text] [Related]

  • 2. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J, Cortiñas P, Loureiro CL, Pujol FH, Medina F, Capote-Negrín L, Bianchi G, García-Barriola V, Ruiz-Benni A, Avilán-Rovira J, Acosta H.
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.
    Siddiqa A, Zainab M, Qadri I, Bhatti MF, Parish JL.
    Viruses; 2014 Jul 17; 6(7):2762-77. PubMed ID: 25036463
    [Abstract] [Full Text] [Related]

  • 4. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL.
    J Med Virol; 2011 Jun 17; 83(6):1034-41. PubMed ID: 21503917
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.
    Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, Huh W.
    Gynecol Oncol; 2015 Apr 17; 137(1):47-54. PubMed ID: 25667973
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846
    [Abstract] [Full Text] [Related]

  • 7. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution.
    Zhang L, Bi Q, Deng H, Xu J, Chen J, Zhang M, Mu X.
    BMC Infect Dis; 2017 Jan 31; 17(1):107. PubMed ID: 28143439
    [Abstract] [Full Text] [Related]

  • 8. Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study.
    Gori S, Battagello J, Gustinucci D, Campari C, Zorzi M, Frayle H, Passamonti B, Sartori G, Bulletti S, Fodero C, Cesarini E, Faggiano R, Del Mistro A.
    BJOG; 2021 Jul 31; 128(8):1353-1362. PubMed ID: 33326680
    [Abstract] [Full Text] [Related]

  • 9. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK, Frederiksen K, Munk C, Iftner T.
    J Natl Cancer Inst; 2010 Oct 06; 102(19):1478-88. PubMed ID: 20841605
    [Abstract] [Full Text] [Related]

  • 10. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.
    Castle PE, Glass AG, Rush BB, Scott DR, Wentzensen N, Gage JC, Buckland J, Rydzak G, Lorincz AT, Wacholder S.
    J Clin Oncol; 2012 Sep 01; 30(25):3044-50. PubMed ID: 22851570
    [Abstract] [Full Text] [Related]

  • 11. Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities.
    Spinillo A, Gardella B, Roccio M, Alberizzi P, Cesari S, Patrizia M, Silini E.
    Cancer Causes Control; 2014 Dec 01; 25(12):1669-76. PubMed ID: 25296710
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
    Simonella LM, Lewis H, Smith M, Neal H, Bromhead C, Canfell K.
    BMC Infect Dis; 2013 Mar 03; 13():114. PubMed ID: 23452957
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2.
    Pajtler M, Milicić-Juhas V, Milojković M, Topolovec Z, Curzik D, Mihaljević I.
    Coll Antropol; 2010 Mar 03; 34(1):81-6. PubMed ID: 20432737
    [Abstract] [Full Text] [Related]

  • 18. Are the human papillomavirus genotypes different in cervical cancer and intraepithelial neoplasia in Jewish Israeli women, a low-risk population?
    Laskov I, Grisaru D, Efrat G, Trejo LL, Grisaru G, Avidor B.
    Int J Gynecol Cancer; 2013 May 03; 23(4):730-4. PubMed ID: 23446379
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M, Xu Q, Li H, Gao H, Bie Y, Zhang Z.
    Medicine (Baltimore); 2016 Jan 03; 95(3):e2555. PubMed ID: 26817906
    [Abstract] [Full Text] [Related]

  • 20. Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study.
    Wu P, Xiong H, Yang M, Li L, Wu P, Lazare C, Cao C, Gao P, Meng Y, Zhi W, Lin S, Hu J, Wei J, Ma D, Liu J, Yin P, Xing H.
    Gynecol Oncol; 2019 Dec 03; 155(3):436-443. PubMed ID: 31604662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.